Product Name:

Frk-pY497


Product Number:

ab-pk641

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Fyn-related kinase; Tyrosine-protein kinase Frk

Target Alias: Nuclear tyrosine protein kinase RAK; PTK5; RAK; GTK; CCDS5103.1; ENSG00000111816

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK642

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y497

Protein UniProt: P42685

Protein SigNET: P42685

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human Frk sequence peptide Cat. No.: PE-04AMN95

Antibody Immunogen Sequence: DSS(pY)SDA(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues D494 to A500; In the C-terminus of the kinase. One of the two major in vivo phosphorylation sites in Frk.

Production Method: Corresponds to amino acid residues D494 to A500; In the C-terminus of the kinase. One of the two major in vivo phosphorylation sites in Frk.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 50-58 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: No significant cross-reactive proteins detected in Jurkat and T98G cells, except phenylarsine oxide (PAO) treatment increases immunoreactivity of 15 kDa protein in Jurkat cells.

Scientific Background: Frk is a protein-tyrosine kinase of the TK group and Src family that is found in the nucleus.. It is involved in positive regulation of PTEN by increasing its stability and preventing degradation and negative regulation of cell proliferation. It may also have functions during G1 and S phase in the nucleus to suppress growth. Frk may be a tumour suppressor protein (TSP). Cancer-related mutations in human tumours point to a loss of function of the protein kinase. nsertional mutagenesis studies in mice support a role for this protein kinase in mouse cancer oncogenesis.